Significant association of cyclin D1 single nucleotide polymorphisms with oral cancer in Taiwan

Anticancer Research

Volumn 31, Issue 1, 2011, Pages 227-231

  Tsai, Ming Hsui ^a   Tsai, Chia Wen ^a,b   Tsou, Yung An ^a   Hua, Chun Hung ^a   Hsu, Chia Fang ^a,c   Bau, Da Tian ^a,b  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c Chang Hua Hospital   (Taiwan)

Author keywords

Cyclin D1; Oral cancer; Polymorphism; Smoking

Indexed keywords

CYCLIN D1;

ADULT; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING HABIT; TAIWAN;

ALLELES; CASE-CONTROL STUDIES; CYCLIN D1; DNA, NEOPLASM; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; TAIWAN;

EID: 79851505310     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Caplan DJ and Hertz-Picciotto I: Racial differences in survival of oral and pharyngeal cancer patients in North Carolina. J Public Health Dent 58: 36-43, 1998. (Pubitemid 128657010)
2. Moore RJ, Doherty DA, Do KA, Chamberlain RM and Khuri FR: Racial disparity in survival of patients with squamous cell carcinoma of the oral cavity and pharynx. Ethn Health 6: 165-177, 2001.
3. Shiboski CH, Shiboski SC and Silverman S Jr.: Trends in oral cancer rates in the United States, 1973-1996. Community Dent Oral Epidemiol 28: 249-256, 2000.
4. Swango PA: Cancers of the oral cavity and pharynx in the United States: an epidemiologic overview. J Public Health Dent 56: 309-318, 1996.
5. Department of Health, Taiwan. Cancer Registration System Annual Report. Taiwan, Department of Health; 2008.
6. Chen L, Elahi A, Pow-Sang J, Lazarus P and Park J: Association between polymorphism of human oxoguanine glycosylase 1 and risk of prostate cancer. J Urol 170: 2471-2474, 2003. (Pubitemid 37414037)
7. Xu J, Zheng SL, Turner A, Isaacs SD, Wiley KE, Hawkins GA, Chang BL, Bleecker ER, Walsh PC, Meyers DA and Isaacs WB: Associations between hOGG1 sequence variants and prostate cancer susceptibility. Cancer Res 62: 2253-2257, 2002. (Pubitemid 34411700)
8. Sherr CJ: D-Type cyclins. Trends Biochem Sci 20: 187-190, 1995.
9. Sherr CJ: Cancer cell cycles. Science 274: 1672-1677, 1996.
10. Coqueret O: Linking cyclins to transcriptional control. Gene 299: 35-55, 2002.
11. Fu M, Wang C, Li Z, Sakamaki T and Pestell RG: Minireview: Cyclin D1: normal and abnormal functions. Endocrinology 145: 5439-5447, 2004. (Pubitemid 39564581)
12. Jayasurya R, Sathyan KM, Lakshminarayanan K, Abraham T, Nalinakumari KR, Abraham EK, Nair MK and Kannan S: Phenotypic alterations in Rb pathway have more prognostic influence than p53 pathway proteins in oral carcinoma. Mod Pathol 18: 1056-1066, 2005. (Pubitemid 41224496)
13. INK4A expression predict reduced survival in carcinoma of the anterior tongue. Clin Cancer Res 5: 2810-2819, 1999. (Pubitemid 29493956)
14. Michalides R, van Veelen N, Hart A, Loftus B, Wientjens E and Balm A: Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res 55: 975-978, 1995.
15. Holley SL, Parkes G, Matthias C, Bockmuhl U, Jahnke V, Leder K, Strange RC, Fryer AA and Hoban PR: Cyclin D1 polymorphism and expression in patients with squamous cell carcinoma of the head and neck. Am J Pathol 159: 1917-1924, 2001.
16. Huang M, Spitz MR, Gu J, Lee JJ, Lin J, Lippman SM and Wu X: Cyclin D1 gene polymorphism as a risk factor for oral premalignant lesions. Carcinogenesis 27: 2034-2037, 2006. (Pubitemid 44530578)
17. Sathyan KM, Nalinakumari KR, Abraham T and Kannan S: Influence of single nucleotide polymorphisms in H-Ras and cyclin D1 genes on oral cancer susceptibility. Oral Oncol 42: 607-613, 2006. (Pubitemid 43947667)
18. Sathyan KM, Nalinakumari KR, Abraham T and Kannan S: CCND1 polymorphisms (A870G and C 1722G) modulate its protein expression and survival in oral carcinoma. Oral Oncol 44: 689-697, 2008. (Pubitemid 351842821)
19. Chang CH, Chiu CF, Wang HC, Wu HC, Tsai RY, Tsai CW, Wang RF, Wang CH, Tsou YA and Bau DT: Significant association of ERCC6 single nucleotide polymorphisms with bladder cancer susceptibility in Taiwan. Anticancer Res 29: 5121-5124, 2009.
20. Chang CH, Wang RF, Tsai RY, Wu HC, Wang CH, Tsai CW, Chang CL, Tsou YA, Liu CS and Bau DT: Significant association of XPD codon 312 single nucleotide polymorphism with bladder cancer susceptibility in Taiwan. Anticancer Res 29: 3903-3907, 2009.
21. Liu CJ, Hsia TC, Wang RF, Tsai CW, Chu CC, Hang LW, Wang CH, Lee HZ, Tsai RY and Bau DT: Interaction of cyclooxygenase 2 genotype and smoking habit in Taiwanese lung cancer patients. Anticancer Res 30: 1195-1199, 2010.
22. Liu CS, Tsai CW, Hsia TC, Wang RF, Liu CJ, Hang LW, Chiang SY, Wang CH, Tsai RY, Lin CC and Bau DT: Interaction of methylenetetrahydrofolate reductase genotype and smoking habit in Taiwanese lung cancer patients. Cancer Genomics Proteomics 6: 325-329, 2009.
23. Wang HC, Chiu CF, Tsai RY, Kuo YS, Chen HS, Wang RF, Tsai CW, Chang CH, Lin CC and Bau DT: Association of genetic polymorphisms of EXO1 gene with risk of breast cancer in Taiwan. Anticancer Res 29: 3897-3901, 2009.
24. Wang HC, Liu CS, Chiu CF, Chiang SY, Wang CH, Wang RF, Lin CC, Tsai RY and Bau DT: Significant association of DNA repair gene Ku80 genotypes with breast cancer susceptibility in Taiwan. Anticancer Res 29: 5251-5254, 2009.
25. Akkiz H, Bayram S, Bekar A, Akgollu E and Ozdil B: Cyclin D1 G870A polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: case-control study. Cancer Epidemiol 34: 298-302, 2010.
26. Rydzanicz M, Golusinski P, Mielcarek-Kuchta D, Golusinski W and Szyfter K: Cyclin D1 gene (CCND1) polymorphism and the risk of squamous cell carcinoma of the larynx. Eur Arch Otorhinolaryngol 263: 43-48, 2006. (Pubitemid 43004710)
27. Canbay E, Eraltan IY, Cercel A, Isbir T, Gazioglu E, Aydogan F, Cacina C, Cengiz A, Ferahman M, Zengin E and Unal H: CCND1 and CDKN1B polymorphisms and risk of breast cancer. Anticancer Res 30: 3093-3098, 2010.
28. Jiang J, Wang J, Suzuki S, Gajalakshmi V, Kuriki K, Zhao Y, Nakamura S, Akasaka S, Ishikawa H and Tokudome S: Elevated risk of colorectal cancer associated with the AA genotype of the cyclin D1 A870G polymorphism in an Indian population. J Cancer Res Clin Oncol 132: 193-199, 2006. (Pubitemid 43015780)
29. Grunhage F, Jungck M, Lamberti C, Berg C, Becker U, Schulte-Witte H, Plassmann D, Rahner N, Aretz S, Friedrichs N, Buettner R, Sauerbruch T and Lammert F: Association of familial colorectal cancer with variants in the E-cadherin (CDH1) and cyclin D1 (CCND1) genes. Int J Colorectal Dis 23: 147-154, 2008. (Pubitemid 350302510)
30. Yuan L, Gu X, Shao J, Wang M, Wang M, Zhu Q and Zhang Z: Cyclin D1 G870A polymorphism is associated with risk and clinicopathologic characteristics of bladder cancer. DNA Cell Biol 29: 611-617, 2010.
31. Yaylim-Eraltan I, Arikan S, Yildiz Y, Cacina C, Ergen HA, Tuna G, Gormus U, Zeybek U and Isbir T: The influence of cyclin D1 A870G polymorphism on colorectal cancer risk and prognosis in a Turkish population. Anticancer Res 30: 2875-2880, 2010.
32. Gomes CC, Drommond SN, Guimaraes AL, Andrade CI, Mesquita RA and Gomez RS: P21/WAF1 and cyclin D1 variants and oral squamous cell carcinoma. J Oral Pathol Med 37: 151-156, 2008.
33. Gangwar R and Mittal RD: Association of selected variants in genes involved in cell cycle and apoptosis with bladder cancer risk in North Indian population. DNA Cell Biol 29: 349-356, 2010.
34. Jain M, Kumar S, Upadhyay R, Lal P, Tiwari A, Ghoshal UC and Mittal B: Influence of apoptosis (BCL2, FAS), cell cycle (CCND1) and growth factor (EGF, EGFR) genetic polymorphisms on survival outcome: an exploratory study in squamous cell esophageal cancer. Cancer Biol Ther 6: 1553-1558, 2007. (Pubitemid 351590326)
35. Satinder K, Chander SR, Pushpinder K, Indu G and Veena J: Cyclin D1 (G870A) polymorphism and risk of cervix cancer: a case control study in north Indian population. Mol Cell Biochem 315: 151-157, 2008.
36. Jayasurya R, Francis G, Kannan S, Lekshminarayanan K, Nalinakumari KR, Abraham T,Abraham EK and Nair MK: p53, p16 and cyclin D1: molecular determinants of radiotherapy treatment response in oral carcinoma. Int J Cancer 109: 710-716, 2004. (Pubitemid 38405618)
37. Betticher DC, Thatcher N, Altermatt HJ, Hoban P, Ryder WD and Heighway J: Alternate splicing produces a novel cyclin D1 transcript. Oncogene 11: 1005-1011, 1995.
38. Sawa H, Ohshima TA, Ukita H, Murakami H, Chiba Y, Kamada H, Hara M and Saito I: Alternatively spliced forms of cyclin D1 modulate entry into the cell cycle in an inverse manner. Oncogene 16: 1701-1712, 1998. (Pubitemid 28175051)
39. Izzo JG, Wu TT, Wu X, Ensor J, Luthra R, Pan J, Correa A, Swisher SG, Chao CK, Hittelman WN and Ajani JA: Cyclin D1 guanine/adenine 870 polymorphism with altered protein expression is associated with genomic instability and aggressive clinical biology of esophageal adenocarcinoma. J Clin Oncol 25: 698-707, 2007. (Pubitemid 350002926)